U.S. market Open. Closes in 6 hours 5 minutes

HZNP | Horizon Therapeutics Public Limited Company Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for HZNP we got that it has average fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is exceptionally good and Health is very strong.

Valuation (29%)

Company Industry
P/E Ratio (TTM) 88.04 47.95
PEG Ratio (TTM) 4.95 2.46
P/S Ratio (TTM) N/A 8.64
P/B Ratio (TTM) 5.01 25.08
P/FCF Ratio (TTM) N/A -43.16
Price to 5YR AVG Earnings Ratio 66.07 59.12
Price to 5YR AVG FCF Ratio 44.64 88.29

Profitability (25%)

Company Industry
ROA (TTM) 3.25% 6.64%
ROE (TTM) 5.86% 31.96%
Net Profit Margin (TTM) 11.11% 13.51%
ROIC 5YR AVG 8.10% 20.64%

Growth (97%)

4QTR AVG 3YR AVG 5YR AVG
EPS 48.84% 279.57% 171.80%
Revenue 2.32% 30.42% 30.07%
Net Income 47.30% 307.45% 191.41%
Cash Flow 17.68% 39.64% 45.34%

Health (77%)

Company Industry
Current Ratio (TTM) 4.27 1.10
Quick Ratio (TTM) 3.50 0.87
D/E Ratio (TTM) 0.48 3.29
Interest Coverage (TTM) 7.64 14.88
Piotroski F-Score 6 6
Altman Z-Score 5.08 4.76
LTL to 5YR AVG FCF 4.27 4.06
Shares Outstanding Growth 5YR AVG 7.32% 1.17%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙